In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses her study which evaluated adults with type 2 diabetes using the t:slim X2 insulin pump with Control-IQ technology to show that Control-IQ technology could offer considerable benefit to individuals with type 2 diabetes.
The abstract entitled: ‘Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes‘ was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022.
Questions:
- What were the aims and design of your study? (0:26)
- What were the findings in terms of time in range? (1:49)
- What was reported in terms of patient satisfaction with the system? (2:56)
Disclosures: Carol Levy is a consultant for Dexcom and Eli Lilly and discloses grant/research support from Abbott Diabetes, Insulet and Tandem.
Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.
Recorded as a highlight of DTM 2022
